ICIn Young Choi

In Young Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


In Young Choi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association between obesity and the risk of gastric cancer in premenopausal and postmenopausal women: A nationwide cohort study

    by In Young Choi, Yoon Jin Choi, Dong Wook Shin, Kyung Do Han, Keun Hye Jeon, Su‐Min Jeong, Jung Eun Yoo

    Background and Aim: Obesity was suggested to increase the incidence of gastric cancer (GC) in women, but results from previous studies were inconsistent. We investigated the relationship between obesity and the risk of GC according to menopausal status.Methods: We enrolled 1 418 180 premenopausal and 4 854 187 postmenopausal women aged ≥ 40 years using the Korean National Health Insurance System Cohort (2009–2014). We calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for GC incidence according to body mass index (BMI) and waist circumference (WC) using the Cox proportional hazards models.Results: During the mean follow‐up period of 7.2 years, 42 441 women were newly diagnosed with GC. Compared with the group with BMI 18.5–22.9 kg/m2, the adjusted HRs (95% CIs) for GC in the groups with BMI < 18.5, 23–24.9, 25–29.9, and ≥ 30 kg/m2 were 1.12 (0.95–1.33), 0.96 (0.89–1.04), 1.02 (0.94–1.11), and 0.99 (0.83–1.18), respectively, for premenopausal women and 1.07 (1.00–1.14), 1.01 (0.99–1.04), 1.03 (1.00–1.05), and 1.11 (1.10–1.16), respectively, for postmenopausal women. Compared with the group with WC 65–74.9 cm, the adjusted HRs (95% CIs) for GC for the groups with WC < 65, 75–84.9, 85–94.9, and ≥ 90 cm were 1.00 (0.88–1.15), 1.03 (0.96–1.11), 1.10 (0.99–1.22), and 1.02 (0.81–1.27), respectively, for premenopausal women and 1.01 (0.94–1.09), 1.01 (0.99–1.04), 1.09 (1.06–1.13), and 1.14 (1.09–1.19), respectively, for postmenopausal women.Conclusions: We found a positive association between the highest BMI and WC category and risk of GC in postmenopausal women; however, such an association was not evident in premenopausal women.


  • Open Access

    Changes in Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study

    by Yohwan Yeo, Kyungdo Han, Dong-Wook Shin, Dahye Kim, Su-Min Jeong, Sohyun Chun, In-Young Choi, Keun-Hye Jeon, Tae-Hyuk Kim

    To elucidate potential causality between smoking and alcohol intake on thyroid cancer incidence, we explored the effect of changes in smoking and alcohol consumption habits. From the Korean National Health Insurance database, we identified 4,430,070 individuals who participated in the national health screening program in 2009 and 2011. The level of smoking and alcohol consumption was measured twice, once in 2009 and again in 2011. The risk of thyroid cancer according to their changes was estimated using the Cox proportional hazard model. During the mean follow-up period of 6.32 ± 0.72 years, 29,447 individuals were diagnosed with thyroid cancer. Compared to those who sustained not smoking, non-smokers who initiated smoking to light (adjusted hazard ratio (aHR) 0.96, 95% confidence interval (CI) 0.81–1.15), moderate (aHR 0.90, 95% CI 0.78–1.04), and heavy level (aHR 0.81, 95% CI 0.69–0.96) had a decreased risk of thyroid cancer. Heavy smokers who quit smoking had an increased risk of thyroid cancer (aHR 1.23, 95% CI 1.06–1.42) compared to those who sustained heavy smoking. Change in drinking status was not significantly associated with thyroid cancer risk compared to drinking at the same level, although a non-significant trend of increased risk was noted in quitters. Participants who initiated both smoking and drinking (HR 0.80, 95% CI 0.69–0.93) had a lower risk of thyroid cancer compared with those who continued not to smoke and drink. Our findings provide further evidence that smoking, and possibly alcohol consumption, would have true protective effects on the development of thyroid cancer.


  • Open Access

    Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study

    by In Young Choi, Sohyun Chun, Dong Wook Shin, Kyungdo Han, Keun Hye Jeon, Jonghan Yu, Byung Joo Chae, Mina Suh, Yong-Moon Park

    Objective: To our knowledge, no studies have yet looked at how the risk of developing breast cancer (BC) varies with changes in metabolic syndrome (MetS) status. This study aimed to investigate the association between changes in MetS and subsequent BC occurrence. Research Design and Methods: We enrolled 930,055 postmenopausal women aged 40–74 years who participated in a biennial National Health Screening Program in 2009–2010 and 2011–2012. Participants were categorized into four groups according to change in MetS status during the two-year interval screening: sustained non-MetS, transition to MetS, transition to non-MetS, and sustained MetS. We calculated multivariable-adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for BC incidence using the Cox proportional hazards models. Results: At baseline, MetS was associated with a significantly increased risk of BC (aHR 1.11, 95% CI 1.06–1.17) and so were all of its components. The risk of BC increased as the number of the components increased (aHR 1.46, 95% CI 1.26–1.61 for women with all five components). Compared to the sustained non-MetS group, the aHR (95% CI) for BC was 1.11 (1.04–1.19) in the transition to MetS group, 1.05 (0.96–1.14) in the transition to non-MetS group, and 1.18 (1.12–1.25) in the sustained MetS group. Conclusions: Significantly increased BC risk was observed in the sustained MetS and transition to MetS groups. These findings are clinically meaningful in that efforts to recover from MetS may lead to reduced risk of BC.


  • Open Access

    Lipid Level, Lipid Variability, and Risk of Multiple Myeloma: A Nationwide Population-Based Study of 3,527,776 Subjects

    by Taewoong Choi, In Young Choi, Kyungdo Han, Su-Min Jeong, Jung Eun Yoo, Sang Youl Rhee, Yong-Gyu Park, Dong Wook Shin

    (1) Background: There is evidence that abnormality in lipid metabolism promotes cancer development. This study investigated whether lipid level and its variability are associated with the development of MM at a population level. (2) Methods: A retrospective cohort study included a total of 3,527,776 subjects aged 40 and above who participated in ≥3 health examinations within the previous five years, including the index year (2012–2013). Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) were measured, and visit-to-visit lipid variability were calculated by variability independent of the mean (VIM) method. The study population was followed from the health examination date in the index year until the diagnosis of MM, death, or the last follow-up date (31 December 2017). (3) Results: During a median (5–95%) 5.1 years of follow-up, 969 subjects developed MM. A lower risk of MM was observed with higher quartiles of baseline lipid levels compared to the lowest quartile group (Q4 vs. Q1: adjusted hazard ratios (aHRs) 0.51, 95% confidence interval (CI) (0.42–0.61) for TC; 0.50 (0.41–0.61) for HDL-C; 0.65 (0.54–0.77) for LDL-C; and 0.72 (0.60–0.87) for TG in model (3). Among all lipid measures, only variability in HDL-C was associated with risk of MM: aHRs (95% CI) were 1.12 (0.91–1.38), 1.19 (0.97–1.46), and 1.34 (1.09–1.65) in the Q2, Q3, and Q4, respectively, compared to the Q1 of VIM of HDL-C. (4) Conclusions: This study shows that patients with lower lipid levels and high HDL-C variability are at increased risk of developing MM.


  • Open Access

    Alternate day fasting impacts the brain insulin‐signaling pathway of young adult male C57BL/6 mice

    by Jianghua Lu, Lezi E, WenFang Wang, Jennifer Frontera, Hao Zhu, Wen‐Tung Wang, Phil Lee, In Young Choi, William M. Brooks, Jeffrey M. Burns, et al.

    J. Neurochem. (2011) 117, 154–163. Dietary restriction (DR) has recognized health benefits that may extend to brain. We examined how DR affects bioenergetics‐relevant enzymes and signaling pathways in the brains of C57BL/6 mice. Five‐month‐old male mice were placed in ad libitum or one of two repeated fasting and refeeding (RFR) groups, an alternate day (intermittent fed; IF) or alternate day plus antioxidants (blueberry, pomegranate, and green tea extracts) (IF + AO) fed group. During the 24‐h fast blood glucose levels initially fell but stabilized within 6 h of starting the fast, thus avoiding frank hypoglycemia. DR in general appeared to enhance insulin sensitivity. After six weeks brain AKT and glycogen synthase kinase 3 beta phosphorylation were lower in the RFR mice, suggesting RFR reduced brain insulin‐signaling pathway activity. Pathways that mediate mitochondrial biogenesis were not activated; AMP kinase phosphorylation, silent information regulator 2 phosphorylation, peroxisomal proliferator‐activated receptor‐gamma coactivator 1 alpha levels, and cytochrome oxidase subunit 4 levels did not change. ATP levels also did not decline, which suggests the RFR protocols did not directly impact brain bioenergetics. Antioxidant supplementation did not affect the brain parameters we evaluated. Our data indicate in young adult male C57BL/6 mice, RFR primarily affects brain energy metabolism by reducing brain insulin signaling, which potentially results indirectly as a consequence of reduced peripheral insulin production.


  • Open Access

    A Case of Autoimmune Chronic Pancreatitis in a Child

    by In Young Choi, So Hee Jin, Kyung Dan Choi, Kyung Mo Kim

    Choi IY, et al. Korean J Pediatr Gastroenterol Nutr. 2007 Sep;10(2):215-220. https://doi.org/10.5223/kjpgn.2007.10.2.215